Search Results - "Delnoy, PPHM"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Management of Nanostim leadless pacemaker early-life battery failures. A single center experience by Oosterwerff, F, Salavati, A, Adiyaman, A, Ghani, A, Smit, JJJ, Ramdat Misier, A, Delnoy, PPHM, Elvan, A

    Published in Europace (London, England) (24-05-2021)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background/introduction Early studies of the Nanostim leadless pacemaker demonstrated…”
    Get full text
    Journal Article
  2. 2

    Real-time image-guided lead placement in cardiac resynchronisation therapy: feasibility and outcome in a multicentre setting by Wouters, PC, Van Slochteren, FJ, Tuinenburg, AE, Doevendans, PAFM, Cramer, MJM, Delnoy, PPHM, Van Dijk, VF, Meine, M

    Published in Europace (London, England) (19-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Introduction Image-guidance to assist left ventricular (LV) lead placement may improve outcome…”
    Get full text
    Journal Article
  3. 3

    Standard stylet-driven Abbott Tendril compared to non-stylet driven Medtronic 3830 in left bundle branch area pacing: procedural duration and acute outcome measures by Daniels, F, Elvan, AE, Adiyaman, A, Aarnink, KM, Oosterwerff, FJ, Delnoy, PPHM, Kanters, MA

    Published in Europace (London, England) (24-05-2021)
    “…Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Maatschap cardiologie Isala Zwolle Right ventricular…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence by Pepplinkhuizen, S, Delnoy, PPHM, Olde Nordkamp, LRA, Kuschyk, J, Bonnemeier, H, Bijsterveld, NR, Boersma, LVA, El-Chami, MF, Smeding, L, Van Der Stuijt, W, De Weger, A, Richter, S, Betts, TR, Wilde, AAM, Knops, RE

    Published in Europace (London, England) (19-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Corporation Background The PRAETORIAN…”
    Get full text
    Journal Article
  6. 6
  7. 7